New Age Alpha Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
14,601
+4,050
+38% +$388K 0.06% 374
2025
Q4
$1.01M Sell
10,551
-12,776
-55% -$1.24M 0.04% 398
2025
Q3
$2.13M Buy
23,327
+11,227
+93% +$1.03M 0.09% 296
2025
Q2
$1.05M Buy
12,100
+11,786
+3,754% +$1,000K 0.05% 412
2025
Q1
$28.2K Buy
314
+26
+9% +$2.33K ﹤0.01% 855
2024
Q4
$23K Buy
288
+98
+52% +$8.48K ﹤0.01% 846
2024
Q3
$17.1K Buy
+190
New +$16K 0.01% 116

Other funds holding MDT

New Age Alpha Advisors's MDT Position: Q1 2026 in Review

New Age Alpha Advisors increased its Medtronic (MDT) stake by 38% in Q1 2026, buying an estimated $388K and bringing the position to 14,601 shares worth $1.27M. The position accounts for 0.06% of the portfolio, ranked #374.

New Age Alpha Advisors first reported a position in MDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.13M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • New Age Alpha Advisors held 14,601 shares of Medtronic worth $1.27M as of Q1 2026.
  • New Age Alpha Advisors bought 4,050 Medtronic shares in Q1 2026, an estimated $388K.
  • Medtronic made up 0.06% of New Age Alpha Advisors's portfolio in Q1 2026, its #374 holding.
  • New Age Alpha Advisors first reported a position in Medtronic in Q3 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Medtronic position peaked at $2.13M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on New Age Alpha Advisors's 13F filing for Q1 2026, filed 11 May 2026.